Latest Whitepapers

The sensitivity and specificity of mass spectrometry (MS) has made it an indispensable tool for biopharmaceutical analysis, ensuring the safety and efficacy of biologics.

Due to the sheer number of possible compounds available, pharmaceutical companies have been adopting high-throughput screening (HTS) methods that can screen chemical libraries rapidly and inexpensively to identify the most promising compounds with activity against a specific biological target.

Innovative strategies to shorten the research and development cycle, increase process efficiency and expedite the drug discovery process are needed.

Binding affinity is a significant factor to consider. However, relying solely on affinity can be problematic, as the highest affinity mAbs may not exhibit optimal activity. To ensure the best lead candidates, it is crucial to consider factors like specificity, selectivity and biological relevance.

This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.

This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.

This whitepaper highlights how the latest software can help researchers overcome the uncertainties in drug discovery and enable efficient compound design, synthesis and progression tracking.

This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.

High-intensity, high-volume cell cultures are an essential part of many bioproduction workflows – especially those operating at scale. However, aggregate accumulation, batch-to-batch cleaning and extensive sterility validation can all negatively impact overall workflow efficiency.

The preparation of process liquids and buffers for in-house bioprocessing can be complex and face many logistical challenges. Additionally, a failure to optimize operational efficiency can result in supply chain disruption, total cost of ownership (TCO) and quality control challenges.